Table 3.
Type of evidence used to change the malaria treatment policy as reported by respondents
| High-quality evidence on drug efficacy (CQ/SP and ACTs) | Guidance provided by WHO | Cries from the community | Evidence on cost | Implementation feasibility | Routine monitoring data | Local and international experiences | Observational evidence from clinicians | Evidence on behavioural change | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Donors | 3 | 3 | 1 | 2 | 1 | 0 | 2 | 1 | 1 | |
| Public sector | Central level MoH | 7 | 6 | 4 | 1 | 1 | ||||
| NMS | ||||||||||
| NDA | 1 | 1 | 1 | |||||||
| Service providers | 1 | 2 | 2 | 1 | 1 | |||||
| Managers at district level | 2 | 1 | 1 | |||||||
| Researchers | 1 | 1 | ||||||||
| Private sector | CSO | 1 | 1 | |||||||
| Pharmaceutical company | 1 | |||||||||
| Media | 1 | 1 | 1 | |||||||
| Service providers | 1 | 2 | ||||||||
| Researchers | 1 | 1 | 1 | 1 | 1 | |||||
| Total | 20 | 15 | 6 | 6 | 5 | 3 | 3 | 3 | 1 |